Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-03

FDA Approved: MILNACIPRAN HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves Camber Pharmaceuticals' original application for milnacipran hydrochloride, a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milnacipran hydrochloride (milnacipran hydrochloride)

Snippet

ORIG AP for MILNACIPRAN HYDROCHLORIDE (MILNACIPRAN HYDROCHLORIDE)